Moderna downsizing investments in late-stage vaccine trials amid U.S. skepticism
Bearish
-50.0
Pharmaceutical company Moderna says it is scaling down its investments in late-stage vaccine trials amid growing opposition to immunizations from U.S. officials. CBS News medical contributor Dr. Céline Gounder breaks it down.
Pulse AI Analysis
Pulse analysis not available yet. Click "Get Pulse" above.
This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.
